E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/22/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Vasomedical discloses details of $2.5 million preferred stock offering

By Sheri Kasprzak

New York, July 22 - Vasomedical Inc. released the details of its previously announced $2.5 million private placement of series D convertible preferred stock.

Monarch Pointe Fund Ltd., Mercator Momentum Fund LP and Mercator Momentum Fund III LP - all managed by M.A.G. Capital LLC - bought 25,000 preferreds at $100 each.

The preferreds are convertible into common shares at 85% of the volume weighted average price for five trading days before conversion. There is a $0.6606 ceiling and a $0.40 floor on the conversion price.

Vasomedical may force conversion of the preferreds if its closing stock price is above $1.30 for more than 20 consecutive trading days.

The preferreds pay monthly cash dividends at Prime plus 300 basis points, with a minimum of 8.5% and maximum of 10%.

The investors also received warrants for 1,892,219 shares, exercisable at $0.69 each through July 19, 2010.

Wharton Capital Partners was the placement agent.

Based in Westbury, N.Y., Vasomedical designs noninvasive treatments for cardiovascular dysfunctions. The proceeds will be used for working capital.

Issuer:Vasomedical, Inc.
Issue:Series D convertible preferred stock
Amount:$2.5 million
Shares:25,000
Price:$100
Dividends:Prime plus 300 basis points, floor of 8.5% , ceiling of 10%
Conversion price:85% of the volume weighted average price for five trading days before conversion, $0.6606 ceiling, $0.40 floor
Warrants:For 1,892,219 shares
Warrant expiration:July 19, 2010
Warrant strike price:$0.69
Placement agent:Wharton Capital Partners
Investors:Monarch Pointe Fund Ltd., Mercator Momentum Fund LP and Mercator Momentum Fund III LP
Settlement date:July 19
Stock price:$0.70 at close July 19

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.